(1888PressRelease)
April 20, 2008 - Dr. Thomas Li, Senior Director of Technology Management at Roche will be speaking at GTCbio’s 2nd Annual Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA. Dr. Li will present on current trends, issues and topics in biomarker discovery, assay development and platform development.
Dr. Li’s presentation is intended to provide an overview on current trends, issues and topics in cancer biomarker discovery, clinical validation and commercial development. Recent published articles on cancer biomarker candidates will be discussed. Examples of diagnostic protein marker panels, multi gene signature and gene expression profiles will be utilized to illustrate the concept of early detection, survival prognostic, treatment selection, response to therapy and companion diagnostics types of biomarkers. Issues of clinical validation in multi-center studies and commercial development and regulatory hurdles will also be discussed.
The 2nd Annual Rediscovering Biomarkers Conference will expose attendees to the latest advancements and developments in biomarkers and predictive medicine. Attendees will gain insight into discovery and development processes, hear about new biomarkers and upcoming trends in the industry, as well as the status of those in clinical trials. Delegates will also receive highly valuable information on tools for improving reimbursement strategies and the efficacy and validation of biomarkers.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=124
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community. GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio ( @ ) gtcbio dot com
